# PET-CT Scan Method to Monitor Pancreatic B-Cell Loss in Diabetes Mellitus

> **NCT00633763** · — · COMPLETED · sponsor: **University of California, Irvine** · enrollment: 30 (estimated)

## Conditions studied

- Type1 Diabetes Mellitus

## Interventions

- **DRUG:** 18F-fallypride
- **DRUG:** 18F-fallypride

## Key facts

- **NCT ID:** NCT00633763
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2009-05-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00633763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00633763, "PET-CT Scan Method to Monitor Pancreatic B-Cell Loss in Diabetes Mellitus". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00633763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*